McCormick Scientific develops and manufactures the innovative histotechnology
tools needed to support a new generation of cancer screening technologies.
The histopathology tests used today to diagnose, identify and differentiate
various forms of cancer require microscopic tissue samples. These biopsy
specimens are smaller than ever before — often only one or two millimeters
in size — and are collected using minimally invasive, image-guided
techniques and then cut into very thin sections for analysis. McCormick
Scientific was formed to provide the new and better tools needed to safely
collect, process, embed, section, store and protect these specimens in
this new, “molecular age” of histopathology.
The company is supported by a strong patent portfolio of new products
and a rich pipeline of new concepts and procedures. The new tissue processing
tools, methods and patents products being developed by Dr. James McCormick
and his staff, in fact, have the potential to dramatically alter the cancer
screening technologies available today and transform the marketplace —
much as Dr. McCormick’s early work transformed the histotechnology
industry in the 1960s.
